Pyxis Oncology | Pyxis Oncology Announces Worldwide Licensing Agreement
https://pyxisoncology.com/2021/03/18/pyxis-oncology-announces-worldwide-licensing-agreement-with-pfizer-to-develop-and-commercialize-multiple-antibody-drug-conjugates/
WebCAMBRIDGE, Mass., March 18, 2021 – Pyxis Oncology (“Pyxis” or the “Company”) today announced that it has entered into a worldwide license agreement with Pfizer Inc. (NYSE:PFE) for the development and commercialization of two antibody-drug conjugate (ADC) candidates and a license to Pfizer’s ADC technology platform, enabling expansion …
DA: 16 PA: 93 MOZ Rank: 22